Abilify
Product Images NDC 64725-0009

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Abilify (NDC 64725-0009). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Tya Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (64725 0009)

Label for ABILIFY 15mg tablets in a 30 count bottle. The label shows it is prescription only with manufacturer listed as Bristol-Myers Squibb, repackaged by TYA Pharmaceuticals in Tallahassee, FL. The label includes a barcode and advises to see package insert for dosage information.*

FDA Label Image

Aripiprazole Chemical Structure (Image 01)

Chemical structure of the active ingredient shown, featuring a chlorine-substituted aromatic ring, a piperazine ring, and an ether-linked side chain attached to a bicyclic ketone structure.*

FDA Label Image

Figure 1: Kaplan-meier Estimation Of Proportion Of Relapses To Any Mood Event For Abilify And Placebo Groups (Image 02)

A Kaplan-Meier plot depicting the proportion at relapse over time (days from randomization) comparing Aripiprazole and Placebo. The graph shows two curves, one solid blue line for Aripiprazole and one dotted red line for Placebo, illustrating relapse rates during the study period.*

FDA Label Image

Otsuka Logo (Image 03)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.